Arcoma AB (ARCOMA) - Total Assets
Based on the latest financial reports, Arcoma AB (ARCOMA) holds total assets worth Skr97.97 Million SEK (≈ $10.54 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ARCOMA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Arcoma AB - Total Assets Trend (2012–2024)
This chart illustrates how Arcoma AB's total assets have evolved over time, based on quarterly financial data. See ARCOMA total equity for net asset value and shareholders' equity analysis.
Arcoma AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Arcoma AB's total assets of Skr97.97 Million consist of 71.3% current assets and 28.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 16.6% |
| Accounts Receivable | Skr17.47 Million | 21.7% |
| Inventory | Skr23.94 Million | 29.8% |
| Property, Plant & Equipment | Skr1.14 Million | 1.4% |
| Intangible Assets | Skr18.49 Million | 23.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Arcoma AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ARCOMA stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arcoma AB's current assets represent 71.3% of total assets in 2024, an increase from 67.3% in 2012.
- Cash Position: Cash and equivalents constituted 16.6% of total assets in 2024, up from 0.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 21.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 29.8% of total assets.
Arcoma AB Competitors by Total Assets
Key competitors of Arcoma AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
Arcoma AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.14 | 2.20 | 1.37 |
| Quick Ratio | 2.04 | 1.24 | 0.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr52.60 Million | Skr33.84 Million | Skr15.70 Million |
Arcoma AB - Advanced Valuation Insights
This section examines the relationship between Arcoma AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.52 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | -1.8% |
| Total Assets | Skr80.46 Million |
| Market Capitalization | $12.93 Million USD |
Valuation Analysis
Below Book Valuation: The market values Arcoma AB's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Arcoma AB's assets decreased by 1.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Arcoma AB (2012–2024)
The table below shows the annual total assets of Arcoma AB from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr80.46 Million ≈ $8.66 Million |
-1.83% |
| 2023-12-31 | Skr81.96 Million ≈ $8.82 Million |
-18.31% |
| 2022-12-31 | Skr100.33 Million ≈ $10.80 Million |
+26.57% |
| 2021-12-31 | Skr79.27 Million ≈ $8.53 Million |
-16.59% |
| 2020-12-31 | Skr95.03 Million ≈ $10.23 Million |
+14.04% |
| 2019-12-31 | Skr83.33 Million ≈ $8.97 Million |
+9.25% |
| 2018-12-31 | Skr76.27 Million ≈ $8.21 Million |
+11.98% |
| 2017-12-31 | Skr68.11 Million ≈ $7.33 Million |
-4.41% |
| 2016-12-31 | Skr71.25 Million ≈ $7.67 Million |
-15.43% |
| 2015-12-31 | Skr84.25 Million ≈ $9.07 Million |
+6.37% |
| 2014-12-31 | Skr79.21 Million ≈ $8.52 Million |
+11.77% |
| 2013-12-31 | Skr70.87 Million ≈ $7.63 Million |
+3.47% |
| 2012-12-31 | Skr68.49 Million ≈ $7.37 Million |
-- |
About Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more